Results 91 to 100 of about 125,918 (262)

Loureirin B Inhibits Hypertrophic Scar Formation via Inhibition of the TGF-β1-ERK/JNK Pathway

open access: yesCellular Physiology and Biochemistry, 2015
Background/Aims: Our previous study confirmed that Loureirin B (LB) can inhibit hypertrophic scar formation. However, the mechanism of LB-mediated inhibition of scar formation is still unknown.
Ting He   +8 more
doaj   +1 more source

Crosslink of Collagen in Hypertrophic Scar

open access: yesJournal of Investigative Dermatology, 1979
It is conceivable that intramolecular and intermolecular crosslinks of collagen may be involved in the formation of hypertrophic scar, but little is known about the relationship between hypertrophic scar and crosslinks of collagen. We have isolated a new crosslinking amino acid from collagen and have named it pyridinoline.
Moriguchi, Takahiko, Fujimoto, Daisaburo
openaire   +2 more sources

Nail Surgery in Children: Specific Challenges and Practical Considerations

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Nail surgery in children represents a specific field within dermatologic surgery. Although the procedures themselves are largely similar to those performed in adults, the indications, technical constraints, and perioperative management differ substantially. Pediatric nail disorders are often clinically recognizable, which frequently limits the
F. Lamoline, B. Richert
wiley   +1 more source

Myocardial Perfusion Defects in Hypertrophic Cardiomyopathy Mutation Carriers

open access: yesJournal of the American Heart Association, EarlyView., 2021
Background Impaired myocardial blood flow (MBF) in the absence of epicardial coronary disease is a feature of hypertrophic cardiomyopathy (HCM). Although most evident in hypertrophied or scarred segments, reduced MBF can occur in apparently normal segments.
Rebecca K. Hughes   +14 more
wiley   +1 more source

Comparing the effects of conventional method, pulse dye laser and erbium laser for the treatment of hypertrophic scars in Iranian patients

open access: yesJournal of Research in Medical Sciences, 2007
<strong>BACKGROUND</strong>: Hypertrophic scar is an elevated scar with ugly appearance that isn&rsquo;t acceptable even in reconstructive surgery. Unfortunately, there is no standard and effective treatment for it.
Mahmod Omranifard, Mehdi Rasti
doaj  

[The hypertrophic scar].

open access: yesMedicina cutanea ibero-latino-americana, 1984
The authors briefly review the literature about hypertrophic scars, emphasizing the etiopathogenesis and treatments, taking in account, the good therapeutic results of pressure-treated scars.
P, Troielli   +2 more
openaire   +1 more source

Adipose Stem Cell-Derived Apoptotic Vesicles Attenuate Hypertrophic Scarring by Targeting the CDC20/WNT Signaling Pathway

open access: yesBiomedicines
Background: Apoptotic vesicles (ApoVs) derived from adipose stem cells (ASCs) have recently emerged as important mediators of tissue repair and are implicated in pathways relevant to hypertrophic scar (HS).
Mengyuan Jiang   +3 more
doaj   +1 more source

Hypertrophic scar in a dog: histological and clinical features

open access: yes, 2011
An adult male bullmastiff dog was treated for paraparesis and ataxia due to discospondylitis and disc herniation. At this time, the dog had a nonhealing ulcer between the pads of the left hindfoot.
Mario Caniatti   +11 more
core   +1 more source

Regeneration of the semitendinosus tendon and muscle after isolated semitendinosus harvest for primary anterior cruciate ligament reconstruction: A systematic review

open access: yesKnee Surgery, Sports Traumatology, Arthroscopy, EarlyView.
Abstract Purpose To systematically evaluate the morphology, temporal evolution and musculoskeletal adaptations associated with semitendinosus tendon (ST) and muscle (SM) regeneration after isolated ST autograft harvest for primary anterior cruciate ligament reconstruction (ACLR).
Maximilian Heinz   +7 more
wiley   +1 more source

MEK Inhibitor Associated Airway Injury in an Infant With Noonan Syndrome: A Case Report

open access: yesThe Laryngoscope, EarlyView.
An infant with Noonan syndrome treated with trametinib developed extensive mucosal sloughing of the upper and lower airway, followed by severe supraglottic scarring. Clinicians should consider airway toxicity as a potential adverse effect of MEK inhibitor therapy.
Veronica Drozdowski‐Nuccio   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy